Advocacy intelligence hub — real-time data for patient organizations
Katarzyna Kotulska — PHASE3
National Heart, Lung, and Blood Institute (NHLBI) — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Travel grants
Travel Grants2
Crestor
(rosuvastatin)Orphan drugstandardiPR Pharmaceuticals, Inc.
12.1 Mechanism of Action CRESTOR is an inhibitor of HMG‑CoA reductase, the rate-limiting enzyme that converts 3‑hydroxy‑3‑methylglutaryl coenzyme A to...
Mary Kay Koenig, MD
The University of Texas Medical School at Houston
📍 Houston, Texas
Joel Moss, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
📍 Bethesda, Maryland
Darcy A Krueger, MD, PhD
Children's Hospital Medical Center, Cincinnati
📍 Birmingham, Alabama
Kim E. Nichols, MD
St. Jude Children's Research Hospital
📍 Memphis, Tennessee
Anna Jansen, MD, PhD
University Hospital, Antwerp
📍 Silver Spring, Maryland